Analysis of reported adverse liver reactions associated with drugs used to treat patients with coronavirus disease 2019. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 59, 2023. DOI: 10.1590/s2175-97902023e21471. Disponível em: https://www.periodicos.usp.br/bjps/article/view/214264.. Acesso em: 9 may. 2024.